جست‌وجوی استاد و پژوهشگر

Tracey Lambمشاهده پروفایل

استاد

• Malaria Immunopathogenesis
• Plasmodium Parasites
• Vaccine Development
• +۳ مورد دیگر

Tracey Lamb is a Professor in the Department of Microbiology and Immunology at the University of Utah. Her research focuses on malaria immunopathogenesis, Plasmodium parasite interactions, and vaccine development. She holds a BSc from the University of Glasgow and a PhD from the University of Edinburgh. Education BSc, University of Glasgow, Scotland PhD, University of Edinburgh, Scotland Lamb's research spans four core areas: Eph receptor tyrosine kinases in malaria pathogenesis, ephrin ligand modulation of T cell responses, co-infection dynamics with pathogens like Epstein-Barr virus, and oral vaccine delivery systems using probiotic yeast. Her lab investigates how Eph receptors contribute to liver fibrosis and cerebral malaria, while exploring probiotic yeast-based vaccines for cost-effective mass distribution. The lab's recent publications highlight trends in malaria research, including molecular mechanisms of endothelial barrier disruption , immune evasion by Plasmodium, CD8+ T cell affinity in disease progression, and ephrin-Eph signaling in immunopathogenesis. Collaborations extend to the Center du Pasteur Cameroon and Emory University's Speck Lab. Labs & Affiliations Lamb Lab, University of Utah Collaborator, Center du Pasteur Cameroon Collaborator, Sam Speck Lab, Emory University Advising Thayer King Patrice Mimche Tuna Ortiz Georgia Veverka Palmer Netongo Pei-Yi Tai Taryn Stewart Scientific Awards

Shawn Owenمشاهده پروفایل

دانشیار

• Protein Engineering
• Bioconjugation
• Cancer Therapeutics
• +۳ مورد دیگر

Dr. Shawn Owen is the Biological Chemistry Program Director at the University of Utah , where he also holds the position of Associate Professor of Molecular Pharmaceutics and Adjunct Associate Professor of Medicinal Chemistry and Biomedical Engineering . His research focuses on protein engineering , bioconjugation , and therapeutic and diagnostic platforms for precision medicine. Education : B.S. and Ph.D. in Chemistry from the University of Utah Departments : Molecular Pharmaceutics, Medicinal Chemistry, Biomedical Engineering Dr. Owen’s research spans antibody-drug conjugates (ADCs), biomaterials for cell-based therapies, and complementation-based diagnostic systems . His work aims to improve the pharmacokinetics of ADCs through self-amplifying designs and develop luminescent immunoassays for biomarker detection. His recent publications (2025–2021) highlight advancements in T-cell immunotherapy , sirtuin activity assays , HER2-targeted therapies , and split-protein diagnostic systems . These studies emphasize applications in cancer treatment , metabolic vulnerabilities , and in vivo molecular imaging . Dr. Owen leads a research laboratory at the University of Utah, utilizing polymeric micelles , hydrogels , and bioconjugation techniques to address challenges in drug delivery and diagnostics.

Karin Ortmayrمشاهده پروفایل

استادیار

• Phytochemistry
• Biodiscovery
• Metabolomics
• +۴ مورد دیگر

Karin Ortmayr serves as an Assistant Professor at the University of Vienna within the Faculty of Life Sciences, Department of Pharmaceutical Sciences, specifically in the Division of Pharmacognosy. Her research laboratory is located in room 2G 154 (floor 1) at Josef-Holaubek-Platz 2, A-1090 Vienna, Austria. Her primary research interests focus on Phytochemistry & Biodiscovery , Molecular Targets , and MS-based metabolome profiling . Dr. Ortmayr investigates the impact of cellular plasticity on cellular metabolism and responses to stress & bioactive compounds. Her work addresses fundamental questions on the interplay between different cell states, cellular metabolism, and the action of bioactive compounds, with particular emphasis on (1) harnessing cell state-specific vulnerabilities to target disease-relevant cell subpopulations like quiescent cancer cells (cancer recurrence), and (2) considering cell state switches to improve cell-based systems for drug discovery. Her research employs advanced analytical tools in mass spectrometry-based metabolomics for systematic studies in human health and disease. She utilizes combined metabolic- and phenotypic profiling approaches, with technologies including mass spectrometry-based metabolomics (non-targeted and targeted), in vitro cell cultivation and multiparallel perturbation studies (96-well format), live-cell microscopy imaging, and integrative computational data analysis. Her publication record demonstrates consistent research output from 2014 through 2025, with a recent focus on metabolic mapping of pharmacological perturbations, biopharmaceutical profiling of natural compounds, and the relationship between cellular plasticity and metabolism in disease contexts. Her work spans microbiology, cancer research, metabolomics, and phytochemistry, reflecting interdisciplinary approaches to understanding metabolic pathways and their therapeutic applications. Dr. Ortmayr utilizes mass spectrometry-based metabolomics as her primary analytical approach, with applications ranging from antibacterial compound discovery to cancer cell metabolism and natural product analysis. Her research bridges fundamental metabolic understanding with practical applications in drug discovery and disease treatment. Her laboratory work involves in vitro cell cultivation, high-throughput perturbation studies, live-cell imaging, and computational data analysis to investigate metabolic responses to various stressors and bioactive compounds. This integrated approach allows for comprehensive analysis of cellular metabolic states and their implications for disease mechanisms and therapeutic interventions.

Nadiia Gumerovaمشاهده پروفایل

پژوهشگر

• Polyoxometalate chemistry
• Structural studies of inorganic complexes
• Ionic equilibria in aqueous solutions
• +۳ مورد دیگر

Nadiia Gumerova , PhD, is a researcher at the Institute of Biophysical Chemistry under the Faculty of Chemistry at the University of Vienna , Austria. Her work focuses on polyoxometalate chemistry, including targeted synthesis, structural analysis, and biomedical applications. She has published extensively on aqueous speciation, metal-substituted polyoxometalates, and their interactions with proteins and biological systems. PhD in Inorganic Chemistry (2014), Donetsk National University Post-doctoral fellow (2019–present), University of Vienna Lise Meitner fellow (2017–2019), University of Vienna Her research interests encompass polyoxometalate design, structural transformations in biological environments, and development of bioactive materials. Recent work includes studies on vanadate-protein interactions, antibiotic activity of Preyssler-type clusters, and enzyme inhibition by polyoxotungstates. Publications (15 most recent) highlight trends in polyoxometalate speciation under varying ionic strengths, biomedical applications of Anderson-Evans and Keggin-type derivatives, and structural insights into metal-substituted tungsten clusters. Keywords span Inorganic Chemistry , Biochemistry , and Materials Science . Grants include the FWF Meitner Program M2203 (2017–2019) and FWF Stand-Alone Project P33927 (2021–2023). She collaborates with the RompelLab and contributes to interdisciplinary projects applying inorganic chemistry in biological contexts.

Joseph Jerryمشاهده پروفایل

استاد

• Molecular Biology
• Cellular Biology
• Cancer Research
• +۴ مورد دیگر

Professor Joseph Jerry is affiliated with the University of Massachusetts Amherst in the Department of Veterinary and Animal Sciences . He serves as Science Director at the Pioneer Valley Life Sciences Institute and Co-Director at the Rays of Hope Center for Breast Cancer Research . Education: M.S., Purdue University Ph.D., The Pennsylvania State University Postdoctoral Training: Jackson Laboratory, Baylor College of Medicine Research Interests: Professor Jerry's work focuses on the p53 tumor suppressor gene , its role in breast cancer susceptibility , and the interplay between genetic modifiers and hormonal/environmental factors . His lab investigates: Estrogen receptor signaling in DNA damage and repair Genetic variation in homology-directed repair pathways Impact of endocrine disruptors on mammary gland development Translational studies using primary breast epithelial cells from human cohorts Role of Notch signaling in stem cell population regulation Mechanisms linking parity to reduced cancer risk Article Trends: Recent work emphasizes environmental chemical exposures (phthalates, parabens, benzophenones), their effects on estrogen receptor-dependent pathways , and nanogel-based drug delivery systems. Publications highlight mouse models for studying gene-environment interactions and interindividual variation in responses to carcinogens. Labs & Collaborations: Co-leads the Rays of Hope Breast Research Registry , collecting samples from over 1,000 women. Collaborates with Baystate Medical Center and utilizes rodent models for mechanistic studies.

• Food Science
• Nutrition
• Sustainable Food Systems
• +۷ مورد دیگر

Francesca Bot is an Associate Professor at the Department of Food and Drug Sciences, University of Parma. Her expertise spans food science, nutrition, and microbiology, with a focus on gut microbiota, probiotics, and functional foods. She teaches courses on food preservation, global food law, and food system sustainability. Academic Appointments: Teacher tutor for Food Science (2024/2025, 2023/2024, 2022/2023) Research Focus: Bifidobacteria microbiome, host-microbe interactions, vitamin biosynthesis, and food-microbiota cross-talk Key Collaborations: Worked with researchers on plant protein stability, gut fermentation models, and microbiota preservation Her recent publications investigate molecular interactions between botanicals and gut microbiota, genetic traits of probiotic strains, and microbiota modulation in stress models. While no specific awards are mentioned, her work spans food chemistry, functional foods, and microbiome applications.

Junco Warrenمشاهده پروفایل

استادیار

• Energy Metabolism
• Mitochondrial Bioenergetics
• Heart Failure Therapy
• +۳ مورد دیگر

Junco Warren, PhD, is an Assistant Professor at the Fralin Biomedical Research Institute and Virginia Tech’s Department of Human Nutrition, Foods, and Exercise. She holds an adjunct appointment at Kumamoto University, Japan. Her research focuses on metabolic reprogramming in heart failure, particularly mechanisms linking energy metabolism dysfunction to cardiac pathology. Key interests include mitochondrial bioenergetics, metabolomics, and epigenetic regulation in cardiac disease. Education: PhD in Pharmacology (SUNY Medical School, 2007), B.A. in International Economics (Aoyama-Gakuin University, 1997). Research Interests: Her work investigates how metabolic dysregulation drives heart failure progression, with emphasis on PERM1 and Smyd1 proteins. Projects include metabolomics-based biomarker discovery and therapeutic strategies targeting mitochondrial function. Awards: Notable recognitions include the 2023 Seale Innovation Award, 2016 BCVS Early Career Investigator Award, and multiple NIH and American Heart Association grants. Grants/Advising: Leads the Warren Lab, mentoring graduate and undergraduate students. Current projects involve PERM1 gene therapy in heart failure models and collaborations on mitochondrial dysfunction mechanisms. Lab Affiliations: Center for Vascular and Heart Research at Fralin, with international collaborations in Japan and the U.S.

• Biomedical Engineering
• Biomaterials
• Tissue Engineering
• +۵ مورد دیگر

Prof. Dr. Ozlem YESIL CELIKTAS is a distinguished academic in the Department of Bioengineering at Ege University's Faculty of Engineering. Her research focuses on biomaterials, tissue engineering, microfluidics, and organ-on-chip systems. She leads cutting-edge projects on 3D bioprinting, environmental pollutant impact modeling, and disease mechanisms using biomimetic platforms. Her work integrates engineering principles with biological systems to address challenges in regenerative medicine and environmental health. Her research interests include: Development of microfluidic-based organ-on-chip models for drug testing and disease study Biomaterial design for tissue regeneration and cell culture systems Environmental toxicology using in vitro and ex vivo models Neurological disorder modeling through brain organoids-on-chip Sustainable development applications in biomaterials and biotechnology Collaborations focus on interdisciplinary teams within Ege University and other institutions, with a strong emphasis on translating lab innovations into clinical applications. Her work contributes to advancing personalized medicine through engineered biological systems.

• Vaccine Development
• Translational Medicine
• Nano Lipid Formulations
• +۳ مورد دیگر

Dr. Sharareh Eskandari is a Research Fellow at Griffith University's Institute for Biomedicine and Glycomics since 2016. She holds a PhD in Chemistry and Molecular Biosciences from the University of Queensland and has industrial experience as an R&D pharmacist. Her research focuses on translational vaccine development, lipid nanoparticle formulations, and adjuvant efficacy studies. Key projects include gonorrhoea vaccine trials and subunit peptide-protein vaccines for SARS-CoV-2. She contributed to a commercial streptococcal vaccine project with Olymvax Biopharmaceuticals (2016–2020) and participated in Phase III trials for the Sanofi Covid-19 vaccine. Awards include the 2021 Glycomics Early Career Research Excellence Award and a FAPESP travel fellowship (2018). Research Interests: Translational drug/vaccine development, nano lipid formulations (liposomes, SLN, NLCs), adjuvant characterisation, and immune response correlations. Peer-reviewed journals include Chemistry - A European Journal , Nanomedicine , and Advanced Drug Delivery Reviews . Professional Activities: Peer reviewer for journals like Journal of Materials Chemistry B and Biomaterials Advances . Member of the Australian Society for Microbiology and the Society for Mucosal Immunology.

Andrew Beharryمشاهده پروفایل

دانشیار

• Biological Chemistry
• Organic Chemistry
• Cancer Biology
• +۳ مورد دیگر

Andrew Beharry is an Associate Professor in the Department of Chemical & Physical Sciences at the University of Toronto Mississauga. His research focuses on developing small molecule probes for cancer biology, including fluorescent chemosensors for drug resistance assessment and activatable photosensitizers for photodynamic therapy (PDT). His lab integrates chemical synthesis, biochemical assays, and in vivo models to create diagnostic tools and treatment platforms that address limitations of conventional cancer therapies. Education & Training: B.Sc. (Honours) in Chemistry and Biology, York University (2006) Ph.D. in Chemistry, University of Toronto (2012) Postdoctoral Fellow, Stanford University (2013–2016), funded by the Human Frontier Science Program Research Interests: Beharry’s lab bridges chemistry and biology to tackle cancer challenges. Key areas include: Fluorescent Chemosensors: Rapid, accurate assays for anticancer drug resistance mechanisms (e.g., DNA repair enzymes, cell death pathways). Activatable Photosensitizers: Cancer-selective PDT agents that enable real-time imaging and therapy via biomarker activation. Fluorescence-Guided Therapies: Combining PDT with surgical imaging to reduce cancer recurrence. Achievements & Funding: Recipient of NSERC Discovery Grant (2017–2022), Connaught New Researcher Award (2017–2019), and Brain Tumour Foundation of Canada Grant (2021–2023). Over 50 publications in high-impact journals like J. Am. Chem. Soc. , ACS Med. Chem. Lett. , and Biochemistry . Labs & Teams: The Beharry Lab collaborates with institutions globally, focusing on translational research from bench to clinic. Current projects include enzyme-activatable prodrugs and theranostic agents for precision oncology.

Hugo Fernandesمشاهده پروفایل

پژوهشگر ارشد

• Neurodegeneration
• Parkinson's Disease
• Alzheimer's Disease
• +۵ مورد دیگر

Hugo Fernandes is a Junior Research Fellow and Group Leader in the Department of Physiology, Anatomy and Genetics at the University of Oxford. He leads a research group focused on understanding early neuronal dysfunction in Parkinson’s and Alzheimer’s diseases, utilizing patient-derived stem cell models to explore lipid dysfunction as a disease mechanism. His work aims to identify novel therapeutic targets to improve patient outcomes. Fernandes holds a DPhil in Neurodegeneration from the University of Oxford (2014) and is affiliated with the Kavli Institute for Nanoscience Discovery. His research interests emphasize stem cell-based disease modeling, lipid metabolism in neurodegeneration, and the application of advanced omics technologies. Key focuses include proteostasis disruptions, mitochondrial dysfunction, and the interplay between genetic mutations (e.g., GBA1, MAPT) and cellular stress pathways. Recent publications highlight his team’s exploration of CRISPR-based genetic screens, single-cell omics, and neuroprotective interventions. Their studies reveal novel insights into lipid dysregulation, ER stress, and therapeutic candidates like KAT2B inhibitors. While no formal students are listed, his group actively contributes to collaborative projects in neurodegenerative disease research. Fernandes’ work integrates molecular, cellular, and systems-level approaches to bridge basic science and clinical translation, with a focus on developing precision medicine strategies for Parkinson’s disease.

Maria Dimakiمشاهده پروفایل

پژوهشگر

• Microfabrication
• Dielectrophoresis
• Microfluidics
• +۵ مورد دیگر

Maria Dimaki is a Senior Researcher at the Technical University of Denmark (DTU), affiliated with the Department of Biotechnology and Biomedicine. Her research focuses on microfabrication, dielectrophoresis, microfluidics, and biosensing, with contributions to nanotechnology and biomedical engineering. She holds a PhD in Dielectrophoretic Assembly of Carbon Nanotube Devices from DTU (2004), preceded by studies in Engineering and Physical Science at Imperial College London (2001) and Electrical Engineering at the National Technical University of Athens (2000). Her research interests include developing advanced microfluidic systems for biomedical applications, such as pathogen detection, milk analysis, and neural studies. She has supervised multiple PhD students, including projects on photonic sensors, bacterial viability classification, and milk contaminant detection. Her work aligns with UN SDGs, particularly addressing sustainable health and innovation. Recent publications emphasize microfluidic platforms for PCR, impedance-based cytometry, and nanoscale sensor technologies. She has co-invented methods for improving milk sample analysis and has participated in international conferences on microfluidics and analytical miniaturization. Her lab integrates nanotechnology, biosensors, and biomedical engineering for innovative diagnostic solutions.

Maureen Smithمشاهده پروفایل

استاد

• Health Services Research
• Healthcare Management
• Telemedicine
• +۵ مورد دیگر

Maureen Smith is a Professor in the Department of Industrial and Systems Engineering at the University of Wisconsin-Madison, with a secondary affiliation in Population Health Sciences. Her research focuses on optimizing healthcare delivery systems, with emphasis on care transitions, telemedicine implementation, and addressing health disparities through system-level interventions. She holds a leadership role in applying operations research methodologies to improve outcomes for older adults and patients with chronic conditions. Key areas of expertise include emergency department workflows, post-acute care coordination, and leveraging electronic health record (EHR) data for population health analytics. Her work integrates clinical decision support systems, machine learning models for risk prediction, and collaborative design processes involving patients, clinicians, and policymakers. Recent studies investigate the role of telehealth in reducing disparities for aging populations, long-term outcomes of organ transplantation technologies, and methodological approaches for community-based behavioral interventions. Dr. Smith collaborates across disciplines to advance translational research in healthcare systems engineering and global public health initiatives. Key Projects: Organ Care System lung transplant outcomes Machine learning tools for fall risk reduction in EDs Statewide health disparity reporting frameworks

Abigail N. Koppesمشاهده پروفایل

دانشیار

• Bioelectric Medicine
• Neural Engineering
• Biomaterials
• +۷ مورد دیگر

Abigail N. Koppes is an Associate Professor of Chemical Engineering at Northeastern University, with affiliations in Bioengineering and the Cross-College Magnetics Center. Her Advanced Biomaterials for NeuroEngineering Laboratory (ABNEL) focuses on bioelectric medicine, nerve regeneration, and organ-on-a-chip systems for gut-brain axis modeling. She holds a B.S., M.S., and Ph.D. in Biomedical Engineering from Rensselaer Polytechnic Institute (2007-2013). Research interests include developing biomaterials and biophysical interventions (e.g., optogenetics, magnetic stimulation) to engineer neural therapies and recapitulate complex biological systems like the enteric nervous system. Notable projects involve neural-guided repair of spinal injuries, gut-on-a-chip platforms for drug discovery, and chronic inflammation modeling. Koppes has secured NIH Trailblazer and NSF CAREER awards, alongside the Rita Schaffer Young Investigator recognition. Her lab integrates techniques from chemical engineering, materials science, and molecular biology to address disorders such as irritable bowel diseases and neurodegenerative conditions. She mentors PhD students (e.g., Bryan Schellberg, Kyla Kaiser) and leads interdisciplinary grants, including NASA-funded neurovascular systems. Recent work includes modeling Sjögren’s syndrome gut-brain axis dysfunction and exploring long-COVID impacts through organ-chip platforms. Koppes collaborates on PEAK undergraduate research programs and has been featured in media for her contributions to bioelectric medicine and personal insights on long-COVID challenges in academia. The ABNEL lab’s innovations span neural engineering, gut-organoid systems, and magnetic stimulation therapies.

Gunnar Kratzمشاهده پروفایل

استاد

• Plastic and Reconstructive Surgery
• Wound Healing
• Tissue Engineering
• +۴ مورد دیگر

Gunnar Kratz is a Professor at Linköping University, affiliated with the Department of Biomedical and Clinical Sciences (BKV) and the Division of Surgery, Orthopedics and Oncology (KOO). He is part of the Wallenberg Centre for Molecular Medicine (WCMM), focusing on medicine-technology interfaces in medical technology, materials science, and bioengineering. His research spans plastic and reconstructive surgery, wound healing mechanisms, antimicrobial treatments, and tissue engineering. Key areas include gender-affirming surgical techniques, cell transplantation using biodegradable scaffolds, and the role of amniotic fluid in keratinocyte behavior. Kratz has contributed to studies on hyaluronic acid's effects on wound healing, novel antimicrobial debridement methods, and ex vivo/in vivo wound models. His work bridges clinical surgery with advanced biomaterials and regenerative medicine. Research interests prominently feature interdisciplinary collaboration, with a focus on translating lab innovations into clinical applications. He has published extensively on topics like gelatin microcarrier-based cell delivery systems, CFSE tracking of transplanted cells, and the analysis of human fibroblast/keratinocyte secreted factors. Kratz’s affiliations include the WCMM at LiU and BKV’s Faculty of Medicine and Health Sciences, emphasizing both clinical and basic research. Notable contributions include a 2019 retrospective study comparing metoidioplasty and phalloplasty outcomes in female-to-male gender-confirming surgery. His 2021 work on autologous cell transplantation via porous gelatin microcarriers highlights advancements in wound healing strategies. Recent studies (2023-2024) explore biphasic bioinks, amino acid-buffered hypochlorite for infected burn wounds, and the role of amniotic fluid in keratinocyte gene expression. Labs/Teams: Active in WCMM’s molecular medicine initiatives and the BKV division’s surgical oncology and orthopedics research programs. Collaborations emphasize bioengineering solutions for clinical challenges in reconstructive surgery and chronic wound management.